Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events

Subsequent Events	3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	7) Subsequent Events After April 1, 2022, the Company issued 22,000 shares of common stock along with issuance of two convertible loans (totaling $200,000). Each loan carries a 12% annual interest rate, a twelve-month term and is convertible at $2.50 per share. In this period, the Company also borrowed $227,000 from related parties with 10% original issue discount and 12% annual interest rate, and repaid $211,000 of related party loans. The Company also entered into a new merchant cash loan arrangement (collecting $225,000 in return for contractual payments of $11,008 per week for 28 weeks). During this period the Company also issued 40,000 shares of common stock to professional services vendors and committed to issue 20,000 shares in three months for service to be provided.

Subsequent Events

3 Months Ended

Mar. 31, 2022

7) Subsequent Events

After April 1, 2022, the Company issued 22,000 shares of common stock along with issuance of two convertible loans (totaling $200,000). Each loan carries a 12% annual interest rate, a twelve-month term and is convertible at $2.50 per share.

In this period, the Company also borrowed $227,000 from related parties with 10% original issue discount and 12% annual interest rate, and repaid $211,000 of related party loans. The Company also entered into a new merchant cash loan arrangement (collecting $225,000 in return for contractual payments of $11,008 per week for 28 weeks). During this period the Company also issued 40,000 shares of common stock to professional services vendors and committed to issue 20,000 shares in three months for service to be provided.